URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...
Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...
Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.
An interim analysis of the prospective BIOPSTAGE trial determined optimal PET thresholds for SUVmax and SUVratio that ...
Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.
Machine Learning Model Predicts Abnormal Lymphocytosis Associated With Chronic Lymphocytic Leukemia Artificial intelligence (AI) tools that identify pathologic features from digitized whole-slide ...
Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.
Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results